DK2128246T3
(da)
*
|
2001-04-19 |
2014-05-12 |
Univ California |
Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
|
US6964859B2
(en)
|
2001-10-16 |
2005-11-15 |
Massachusetts Institute Of Technology |
Suppressor tRNA system
|
US20030148391A1
(en)
*
|
2002-01-24 |
2003-08-07 |
Salafsky Joshua S. |
Method using a nonlinear optical technique for detection of interactions involving a conformational change
|
US7112435B1
(en)
|
2002-08-07 |
2006-09-26 |
Ambit Biosciences Corporation |
Uncoupling of DNA insert propagation and expression of protein for phage display
|
US20040038273A1
(en)
*
|
2002-06-17 |
2004-02-26 |
Whitehead Institute For Biomedical Research |
Bifunctional tRNA for in vitro selection
|
CA2493798A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Mds Proteomics Inc. |
Improved systems and methods for analysis of protein post-translational modification
|
US7833741B2
(en)
*
|
2002-08-07 |
2010-11-16 |
Ambit Biosciences Corporation |
Uncoupling of DNA insert propagation and expression of protein for phage display
|
US7897381B2
(en)
*
|
2002-08-07 |
2011-03-01 |
Ambit Biosciences Corporation |
Uncoupling of DNA insert propagation and expression of protein for phage display
|
US7563600B2
(en)
*
|
2002-09-12 |
2009-07-21 |
Combimatrix Corporation |
Microarray synthesis and assembly of gene-length polynucleotides
|
JP4444113B2
(ja)
*
|
2002-10-16 |
2010-03-31 |
ザ スクリップス リサーチ インスティテュート |
ケトアミノ酸の部位特異的蛋白質組込み方法
|
ATE445709T1
(de)
|
2002-10-16 |
2009-10-15 |
Scripps Research Inst |
Glycoproteinsynthese
|
US7642085B2
(en)
|
2002-12-22 |
2010-01-05 |
The Scripps Research Institute |
Protein arrays
|
PT1583562E
(pt)
|
2003-01-06 |
2011-09-19 |
Angiochem Inc |
Angiopep-1, compostos relacionados, e suas utilizações
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
JP2006180701A
(ja)
*
|
2003-02-10 |
2006-07-13 |
Institute Of Physical & Chemical Research |
チロシルtRNA合成酵素の変異体及びその作製方法
|
AU2013201487B2
(en)
*
|
2003-04-17 |
2014-09-18 |
The Scripps Research Institute |
Expanding the eukaryotic genetic code
|
KR101171397B1
(ko)
*
|
2003-04-17 |
2012-08-07 |
더 스크립스 리서치 인스티튜트 |
진핵 유전자 코드의 확장
|
WO2004110964A2
(en)
*
|
2003-06-16 |
2004-12-23 |
Nuevolution A/S |
Encoded molecules by translation (emt)
|
US7993872B2
(en)
|
2003-06-18 |
2011-08-09 |
The Scripps Research Institute |
Unnatural reactive amino acid genetic code additions
|
US20060160175A1
(en)
*
|
2003-07-07 |
2006-07-20 |
The Scripps Research Institute |
Compositions of orthogonal leucyl-trna and aminoacyl-trna synthetase pairs and uses thereof
|
EP1658366A4
(en)
*
|
2003-07-07 |
2006-08-09 |
Scripps Research Inst |
COMPOSITIONS OF ORTHOGONAL GLUTAMYL-TRNA AND AMINOACYL-TRNA-SYNTHETASEPAARES AND THEIR USES
|
WO2005019415A2
(en)
*
|
2003-07-07 |
2005-03-03 |
The Scripps Research Institute |
Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
|
WO2005047461A2
(en)
|
2003-08-18 |
2005-05-26 |
The Regents Of The University Of California |
Polypeptide display libraries and methods of making and using thereof
|
DK1687401T3
(da)
|
2003-10-14 |
2013-02-04 |
Scripps Research Inst |
Sted-spicifik inkorporing af redoxaktive aminosyrer i protiener
|
AU2004314710A1
(en)
*
|
2003-12-12 |
2005-08-11 |
Conjugon, Inc. |
Systems for tightly regulated gene expression
|
CA2549830A1
(en)
*
|
2003-12-18 |
2006-01-05 |
The Scripps Research Institute |
Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells
|
JP2007519422A
(ja)
|
2004-02-02 |
2007-07-19 |
アンブレツクス・インコーポレイテツド |
修飾されたヒト四螺旋バンドルポリペプチド及びそれらの使用
|
WO2005089110A2
(en)
*
|
2004-02-27 |
2005-09-29 |
President And Fellows Of Harvard College |
Polynucleotide synthesis
|
FR2868081A1
(fr)
*
|
2004-03-23 |
2005-09-30 |
Libragen Sa |
Methode d'identification de famille de voie metabolique par selection positive
|
US20050260711A1
(en)
*
|
2004-03-30 |
2005-11-24 |
Deepshikha Datta |
Modulating pH-sensitive binding using non-natural amino acids
|
WO2005100560A1
(ja)
*
|
2004-04-09 |
2005-10-27 |
Chugai Seiyaku Kabushiki Kaisha |
細胞死誘導剤
|
US20050287639A1
(en)
|
2004-05-17 |
2005-12-29 |
California Institute Of Technology |
Methods of incorporating amino acid analogs into proteins
|
EP1774018A2
(en)
*
|
2004-05-25 |
2007-04-18 |
The Scripps Research Institute |
Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
|
US20060008844A1
(en)
*
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
MXPA06014684A
(es)
*
|
2004-06-18 |
2007-02-12 |
Ambrx Inc |
Novedosos polipeptidos de enlace antigeno y sus usos.
|
CN1968712B
(zh)
*
|
2004-06-18 |
2012-05-16 |
Ambrx公司 |
新颖抗原结合多肽和其用途
|
PL1771474T3
(pl)
|
2004-07-20 |
2010-07-30 |
Genentech Inc |
Inhibitory białka angiopoetyno-4-podobnego, kombinacje i ich zastosowanie
|
AU2005327906B2
(en)
*
|
2004-07-21 |
2010-05-13 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
JP2008513039A
(ja)
*
|
2004-09-21 |
2008-05-01 |
ザ スクリップス リサーチ インスティテュート |
真正細菌の蛋白質へのアルキニルアミノ酸のインビボ組込み
|
US20060110784A1
(en)
*
|
2004-09-22 |
2006-05-25 |
The Scripps Research Institute |
Site-specific labeling of proteins for NMR studies
|
US20070122817A1
(en)
*
|
2005-02-28 |
2007-05-31 |
George Church |
Methods for assembly of high fidelity synthetic polynucleotides
|
EP1812598A1
(en)
*
|
2004-10-18 |
2007-08-01 |
Codon Devices, Inc. |
Methods for assembly of high fidelity synthetic polynucleotides
|
US20080064059A1
(en)
*
|
2004-10-20 |
2008-03-13 |
Scripps Research Institute |
In Vivo Site-Specific Incorporation of N-Acetyl-Galactosamine Amino Acids in Eubacteria
|
CA2583735A1
(en)
|
2004-10-27 |
2006-10-19 |
The Scripps Research Institute |
Orthogonal translation components for the in vivo incorporation of unnatural amino acids
|
AU2011204773B2
(en)
*
|
2004-10-27 |
2012-02-02 |
The Scripps Research Institute |
Orthogonal translation components for the in vivo incorporation of unnatural amino acids
|
SI2586456T1
(sl)
|
2004-10-29 |
2016-05-31 |
Ratiopharm Gmbh |
Preoblikovanje in glikopegliacija fibroblastnega rastnega faktorja (FGF)
|
WO2006055898A2
(en)
*
|
2004-11-20 |
2006-05-26 |
Massachusetts Institute Of Technology |
Orthogonal suppressor trnas and aminoacyl-trna synthetases and uses thereof
|
EP1818400A4
(en)
*
|
2004-11-22 |
2008-11-05 |
Univ Gifu |
METHOD FOR THE JOB-SPECIFIC INTRODUCTION OF UNNATURAL AMINOIC ACID IN PROTEIN USING A MITOCHONDRIAL PROTEIN AND METHOD FOR THE EFFECTIVE MANUFACTURE OF TRNA
|
ATE541934T1
(de)
|
2004-12-22 |
2012-02-15 |
Ambrx Inc |
Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
|
SG161210A1
(en)
|
2004-12-22 |
2010-05-27 |
Ambrx Inc |
Methods for expression and purification of recombinant human growth hormone
|
WO2006069246A2
(en)
*
|
2004-12-22 |
2006-06-29 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
AU2013205042B2
(en)
*
|
2004-12-22 |
2016-05-12 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
BRPI0519430A2
(pt)
|
2004-12-22 |
2009-02-10 |
Ambrx Inc |
hormânio do crescimento humano modificado
|
AU2005322019B2
(en)
*
|
2004-12-22 |
2010-08-26 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
WO2006107813A2
(en)
*
|
2005-04-05 |
2006-10-12 |
Yale University |
Site specific incorporation of phosphoserine into polypeptides using phosphoseryl-trna synthetase
|
WO2006121569A2
(en)
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
WO2006122224A1
(en)
|
2005-05-11 |
2006-11-16 |
Wayne State University |
Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
|
KR20080026135A
(ko)
|
2005-06-03 |
2008-03-24 |
암브룩스, 인코포레이티드 |
개선된 인간 인터페론 분자 및 이의 용도
|
JP2008541766A
(ja)
*
|
2005-06-03 |
2008-11-27 |
アンブレツクス・インコーポレイテツド |
タンパク質中への天然にコードされないアミノ酸の取り込み
|
CA2610987C
(en)
*
|
2005-06-10 |
2013-09-10 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilizer for protein preparation comprising meglumine and use thereof
|
WO2007005053A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Codon Devices, Inc. |
Hierarchical assembly methods for genome engineering
|
CA2614326C
(en)
*
|
2005-07-15 |
2012-09-18 |
Medical Research Council |
Compositions and methods relating to orthogonal ribosome mrna pairs
|
DK2433653T3
(da)
|
2005-07-15 |
2019-08-19 |
Angiochem Inc |
Anvendelse af aprotininpolypeptider som bærere i farmaceutiske konjugater
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
MX2008002149A
(es)
*
|
2005-08-18 |
2008-04-22 |
Ambrx Inc |
Composiciones de arnt y sus usos.
|
EP2535346B1
(en)
*
|
2005-08-31 |
2017-08-02 |
The Regents of The University of California |
Cellular libraries of peptide sequences (CLiPS) and methods of using the same
|
RU2459866C2
(ru)
*
|
2005-10-12 |
2012-08-27 |
Зе Скрипс Ресеч Инститьют |
Селективная посттрансляционная модификация экспонируемых фагами полипептидов
|
EP2339014B1
(en)
|
2005-11-16 |
2015-05-27 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
KR101423898B1
(ko)
|
2005-12-14 |
2014-07-28 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
|
EP1963536B1
(en)
|
2005-12-22 |
2016-05-04 |
Pacific Biosciences of California, Inc. |
Polymerases for nucleotide analogue incorporation
|
AU2006332809A1
(en)
*
|
2005-12-30 |
2007-07-12 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
AU2007215566A1
(en)
*
|
2006-01-19 |
2007-08-23 |
Ambrx, Inc. |
Non-natural amino acid polypeptides having modulated immunogenicity
|
WO2007090198A2
(en)
*
|
2006-02-01 |
2007-08-09 |
Encode Bio, Inc. |
Fluorescent assays using orthogonal trna - aminoacyl synthetase pairs
|
US20070178554A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Nima Shiva |
Orthogonal Aminoacyl Synthetase-tRNA Pairs for Incorporating Unnatural Amino Acids Into Proteins
|
US7776535B2
(en)
|
2006-02-06 |
2010-08-17 |
Franklin And Marshall College |
Site-specific incorporation of fluorinated amino acids into proteins
|
US8518666B2
(en)
|
2006-03-03 |
2013-08-27 |
California Institute Of Technology |
Site-specific incorporation of amino acids into molecules
|
CN101400796B
(zh)
*
|
2006-03-09 |
2013-03-27 |
斯克利普斯研究院 |
在真细菌宿主细胞内表达正交翻译组分的系统
|
RU2464315C2
(ru)
|
2006-03-16 |
2012-10-20 |
Зе Скрипс Ресеч Инститьют |
Генетически запрограммированная экспрессия белков, содержащих не встречающуюся в природе аминокислоту фенилселеноцистеин
|
US20080096819A1
(en)
*
|
2006-05-02 |
2008-04-24 |
Allozyne, Inc. |
Amino acid substituted molecules
|
WO2007130453A2
(en)
|
2006-05-02 |
2007-11-15 |
Allozyne, Inc. |
Non-natural amino acid substituted polypeptides
|
JP2009538136A
(ja)
*
|
2006-05-23 |
2009-11-05 |
ザ スクリップス リサーチ インスティテュート |
遺伝的にコードされた蛍光クマリンアミノ酸
|
TWI427084B
(zh)
*
|
2006-06-09 |
2014-02-21 |
Novartis Ag |
穩定化之類胰島素生長因子多肽
|
WO2008001947A1
(fr)
*
|
2006-06-28 |
2008-01-03 |
Riken |
SepRS MUTANTE, ET PROCÉDÉ D'INTRODUCTION SITO-SPÉCIFIQUE D'UNE PHOSPHOSÉRINE DANS UNE PROTÉINE EN UTILISANT CETTE SepRS
|
CA2657811C
(en)
*
|
2006-06-29 |
2014-10-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-free synthesis of proteins containing unnatural amino acids
|
CA2657385A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Naoki Kimura |
Cell death inducer
|
AU2007292891B2
(en)
*
|
2006-09-08 |
2012-04-12 |
Ambrx, Inc. |
Site specific incorporation of non-natural amino acids by vertebrate cells
|
AU2012203737B2
(en)
*
|
2006-09-08 |
2014-06-19 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
NZ574721A
(en)
*
|
2006-09-08 |
2012-02-24 |
Ambrx Inc |
Hybrid suppressor trna for vertebrate cells
|
US8420792B2
(en)
|
2006-09-08 |
2013-04-16 |
Ambrx, Inc. |
Suppressor tRNA transcription in vertebrate cells
|
AU2013202770B2
(en)
*
|
2006-09-08 |
2015-08-20 |
Ambrx, Inc. |
Modified human plasma polypeptide or Fc scaffolds and their uses
|
EP2069396B1
(en)
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and their uses
|
CN101516901B
(zh)
*
|
2006-09-21 |
2014-01-08 |
斯克利普斯研究院 |
选择性硫酸化的蛋白质在真细菌中的遗传编程表达
|
AU2007333010A1
(en)
|
2006-10-18 |
2008-06-19 |
The Scripps Research Institute |
Genetic incorporation of unnatural amino acids into proteins in mammalian cells
|
EP2120998B1
(en)
|
2006-11-28 |
2013-08-07 |
HanAll Biopharma Co., Ltd. |
Modified erythropoietin polypeptides and uses thereof for treatment
|
EP1936340A1
(en)
*
|
2006-12-21 |
2008-06-25 |
Koninklijke Philips Electronics N.V. |
Sub wavelength aperture
|
US20100143980A1
(en)
*
|
2007-02-22 |
2010-06-10 |
Kuberan Balagurunathan |
Synthesis of novel xylosides and potential uses thereof
|
CL2008000719A1
(es)
*
|
2007-03-12 |
2008-09-05 |
Univ Tokushima Chugai Seiyaku |
Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
|
BRPI0809583B1
(pt)
|
2007-03-30 |
2022-02-22 |
Ambrx, Inc |
Polipeptídeo fgf-21 modificado, composição compreendendo o mesmo, método para produzir o referido polipetídeo fgf-21 e célula compreendendo um polinucleotídeo
|
US8183037B2
(en)
*
|
2007-04-13 |
2012-05-22 |
The Salk Institute For Biological Studies |
Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal tRNA/synthetase pairs
|
CA2685596A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Ambrx, Inc. |
Modified interferon beta polypeptides and their uses
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
US7879802B2
(en)
|
2007-06-04 |
2011-02-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US20100120694A1
(en)
|
2008-06-04 |
2010-05-13 |
Synergy Pharmaceuticals, Inc. |
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
CA2707840A1
(en)
|
2007-08-20 |
2009-02-26 |
Allozyne, Inc. |
Amino acid substituted molecules
|
WO2009036460A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Ambrx, Inc. |
Modified human apolipoprotein a-i polypeptides and their uses
|
CA2702061A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Synthetic Genomics, Inc. |
System and method for producing synthetic microorganisms capable of translating proteins containing non-standard amino acids
|
CA2703736A1
(en)
*
|
2007-10-25 |
2009-04-30 |
The Scripps Research Institute |
Genetic incorporation of 3-aminotyrosine into reductases
|
US9249408B2
(en)
*
|
2007-11-02 |
2016-02-02 |
The Scripps Research Institute |
Directed evolution using proteins comprising unnatural amino acids
|
WO2009059056A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Scripps Research Institute |
A genetically encoded boronate amino acid
|
DK2567709T3
(en)
|
2007-11-02 |
2018-03-12 |
Novartis Ag |
Molecules and Methods for Modulating Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6)
|
WO2009064416A2
(en)
*
|
2007-11-15 |
2009-05-22 |
The Scripps Research Institute |
Genetic incorporation of an alpha-hydroxy acid into proteins to generate ester backbone linkages at defined sites
|
NZ603812A
(en)
*
|
2007-11-20 |
2014-06-27 |
Ambrx Inc |
Modified insulin polypeptides and their uses
|
CN105647824A
(zh)
*
|
2007-12-11 |
2016-06-08 |
斯克利普斯研究院 |
甲基营养酵母菌巴斯德毕赤酵母中的体内非天然氨基酸表达
|
AU2008347234B2
(en)
|
2008-01-03 |
2015-05-28 |
Basf Enzymes Llc |
Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
|
WO2009099763A1
(en)
|
2008-01-30 |
2009-08-13 |
Indiana University Research And Technology Corporation |
Ester-based peptide prodrugs
|
SG188143A1
(en)
|
2008-02-08 |
2013-03-28 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
MX2010008633A
(es)
*
|
2008-02-08 |
2010-09-30 |
Scripps Research Inst |
Ruptura de tolerancia inmunologica con un aminoacido no natural geneticamente codificado.
|
WO2009117622A2
(en)
*
|
2008-03-19 |
2009-09-24 |
Ambrx, Inc. |
Modified fgf-23 polypeptides and their uses
|
US8940506B2
(en)
*
|
2008-03-21 |
2015-01-27 |
The Regents Of The University Of California |
High-sensitive fluorescent energy transfer assay using fluoresent amino acids and fluorescent proteins
|
JP5425180B2
(ja)
|
2008-03-27 |
2014-02-26 |
ザイモジェネティクス, インコーポレイテッド |
PDGFRβおよびVEGF−Aを阻害するための組成物および方法
|
WO2009145820A2
(en)
|
2008-03-31 |
2009-12-03 |
Pacific Biosciences Of California, Inc. |
Generation of modified polymerases for improved accuracy in single molecule sequencing
|
EP2439212B1
(en)
|
2008-05-02 |
2016-12-21 |
Novartis AG |
Improved fibronectin-based binding molecules and uses thereof
|
MX2010014079A
(es)
|
2008-06-20 |
2011-02-22 |
Novartis Ag |
Inmunoglobulinas con agregacion reducida.
|
JP5756751B2
(ja)
|
2008-06-26 |
2015-07-29 |
エータイアー ファーマ, インコーポレイテッド |
非正準的な生物学的活性を有するグリシル−tRNA合成酵素を含む組成物および方法
|
CN102089431A
(zh)
|
2008-06-30 |
2011-06-08 |
艾斯巴技术,爱尔康生物医药研究装置有限责任公司 |
官能化的多肽
|
EP2769711A1
(en)
*
|
2008-07-10 |
2014-08-27 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Methods and Compositions for Enhanced Delivery of Macromolecules
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
NZ591235A
(en)
|
2008-07-23 |
2012-07-27 |
Ambrx Inc |
Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
|
US9182406B2
(en)
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
WO2010022171A1
(en)
*
|
2008-08-19 |
2010-02-25 |
Ferring International Center S.A. |
Peptidic pth receptor agonists
|
TR201802361T4
(tr)
|
2008-09-26 |
2018-03-21 |
Ambrx Inc |
Doğal olmayan amino asit replikasyonuna bağımlı mikroorganizmalar ve aşılar.
|
PL2342223T3
(pl)
|
2008-09-26 |
2017-09-29 |
Ambrx, Inc. |
Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
|
JP2012505637A
(ja)
|
2008-10-15 |
2012-03-08 |
アンジオケム,インコーポレーテッド |
Glp−1アゴニストのコンジュゲート及びその使用
|
KR101316159B1
(ko)
|
2008-10-24 |
2013-10-15 |
아이알엠 엘엘씨 |
생합성적으로 생성된 피롤린-카르복시-리신, 및 피롤린-카르복시-리신 및 피롤리신 잔기의 화학적 유도체화를 통한 부위 특이적 단백질 변형
|
CN102307904A
(zh)
|
2008-12-05 |
2012-01-04 |
安吉奥开米公司 |
神经降压素或神经降压素类似物的缀合物及其用途
|
EP2370473B1
(en)
|
2008-12-10 |
2016-05-11 |
The Scripps Research Institute |
Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
|
US20090197339A1
(en)
*
|
2008-12-10 |
2009-08-06 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
|
CN102300987A
(zh)
|
2008-12-17 |
2011-12-28 |
安吉奥开米公司 |
膜型-1基质金属蛋白抑制剂及其用途
|
AU2009335715B2
(en)
|
2008-12-19 |
2016-09-15 |
Indiana University Research And Technology Corporation |
Amide-based insulin prodrugs
|
AR074811A1
(es)
|
2008-12-19 |
2011-02-16 |
Univ Indiana Res & Tech Corp |
Profarmaco de peptido de la superfamilia de glucagon basados en amida
|
WO2010080606A1
(en)
|
2008-12-19 |
2010-07-15 |
Indiana University Research And Technology Corporation |
Insulin analogs
|
CN102300580A
(zh)
*
|
2008-12-19 |
2011-12-28 |
印第安纳大学研究及科技有限公司 |
二肽连接的药剂
|
US9238878B2
(en)
|
2009-02-17 |
2016-01-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
ES2552773T3
(es)
|
2009-02-27 |
2015-12-02 |
Atyr Pharma, Inc. |
Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
|
CN102449143B
(zh)
*
|
2009-03-31 |
2017-11-14 |
Atyr医药公司 |
包含具有非常规生物活性的天冬氨酰‑tRNA合成酶的组合物和方法
|
US9173891B2
(en)
|
2009-04-20 |
2015-11-03 |
Angiochem, Inc. |
Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
|
EP2430164B1
(en)
|
2009-05-11 |
2017-07-19 |
Pfenex, Inc. |
Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
|
CN102458479B
(zh)
|
2009-06-04 |
2016-07-13 |
诺华公司 |
识别IgG结合位点的方法
|
RU2012103240A
(ru)
|
2009-07-02 |
2013-08-10 |
Ангиокем Инк. |
Мультимерные пептидные конъюгаты и их применение
|
US10292956B2
(en)
|
2009-09-01 |
2019-05-21 |
Serbig Pharmaceutics Corp. |
Cancer starvation therapy
|
US20110054019A1
(en)
*
|
2009-09-01 |
2011-03-03 |
Pedro Anastacio Serrano-Ojeda |
Cancer Starvation Therapy
|
EP2311947A1
(en)
*
|
2009-10-14 |
2011-04-20 |
Ludwig-Maximilians-Universität München |
Protein synthesis via click chemistry
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
WO2011051327A2
(en)
|
2009-10-30 |
2011-05-05 |
Novartis Ag |
Small antibody-like single chain proteins
|
WO2011051466A1
(en)
|
2009-11-02 |
2011-05-05 |
Novartis Ag |
Anti-idiotypic fibronectin-based binding molecules and uses thereof
|
JP2013509869A
(ja)
|
2009-11-05 |
2013-03-21 |
ノバルティス アーゲー |
線維症の進行の予測用バイオマーカー
|
US9051593B2
(en)
|
2009-12-21 |
2015-06-09 |
Trustees Of Dartmouth College |
Recombinant prokaryotes and use thereof for production of O-glycosylated proteins
|
CN104017063A
(zh)
|
2009-12-21 |
2014-09-03 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
NZ600361A
(en)
|
2009-12-21 |
2014-06-27 |
Ambrx Inc |
Modified bovine somatotropin polypeptides and their uses
|
JP6210685B2
(ja)
|
2010-01-27 |
2017-10-11 |
マサチューセッツ インスティテュート オブ テクノロジー |
標的化された広域スペクトルのインフルエンザ中和のための操作されたポリペプチド剤
|
WO2011092233A1
(en)
|
2010-01-29 |
2011-08-04 |
Novartis Ag |
Yeast mating to produce high-affinity combinations of fibronectin-based binders
|
CA2789125A1
(en)
|
2010-02-10 |
2011-08-18 |
Novartis Ag |
Methods and compounds for muscle growth
|
US8674064B2
(en)
*
|
2010-03-03 |
2014-03-18 |
Onkologix Ltd |
Immunogenic compositions against human progastrin peptides
|
US8464858B2
(en)
*
|
2010-03-12 |
2013-06-18 |
Cabin Creek Inc. |
Conveyor belt scraper and system for the same
|
US20130078660A1
(en)
*
|
2010-03-23 |
2013-03-28 |
Salk Institute For Biological Studies |
Methods and compositions for detecting protein modifications
|
CN103118692A
(zh)
|
2010-04-26 |
2013-05-22 |
Atyr医药公司 |
与半胱氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
JP6294074B2
(ja)
|
2010-04-27 |
2018-03-14 |
エータイアー ファーマ, インコーポレイテッド |
イソロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
US8986681B2
(en)
|
2010-04-27 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
|
US8993723B2
(en)
|
2010-04-28 |
2015-03-31 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
|
US8986680B2
(en)
|
2010-04-29 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
|
WO2011150279A2
(en)
*
|
2010-05-27 |
2011-12-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
CN103118693B
(zh)
|
2010-04-29 |
2017-05-03 |
Atyr 医药公司 |
与缬氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
WO2011139988A2
(en)
|
2010-05-03 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
|
US8961961B2
(en)
|
2010-05-03 |
2015-02-24 |
a Tyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
|
EP2566496B1
(en)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
|
AU2011248227B2
(en)
|
2010-05-03 |
2016-12-01 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
US9062301B2
(en)
|
2010-05-04 |
2015-06-23 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
|
WO2011140267A2
(en)
|
2010-05-04 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
CN103200953B
(zh)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011256366C1
(en)
|
2010-05-17 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
|
EP2575857B1
(en)
|
2010-06-01 |
2018-01-24 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
|
WO2011158895A1
(ja)
*
|
2010-06-16 |
2011-12-22 |
独立行政法人理化学研究所 |
非天然タンパク質製造用の組換え細菌の作製方法、及びその利用
|
CA2802485C
(en)
|
2010-06-16 |
2019-09-17 |
Indiana University Research And Technology Corporation |
Single chain insulin agonists exhibiting high activity at the insulin receptor
|
WO2011163012A2
(en)
|
2010-06-24 |
2011-12-29 |
Indiana University Research And Technology Corporation |
Amide based glucagon superfamily peptide prodrugs
|
CN103119057B
(zh)
|
2010-06-24 |
2016-06-15 |
印第安纳大学研究及科技有限公司 |
基于酰胺的胰岛素前药
|
CA2804278C
(en)
|
2010-07-12 |
2021-07-13 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
|
AU2011289831C1
(en)
*
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
WO2012021249A2
(en)
*
|
2010-07-12 |
2012-02-16 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
|
US8999321B2
(en)
|
2010-07-12 |
2015-04-07 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
MY162837A
(en)
|
2010-08-17 |
2017-07-31 |
Ambrx Inc |
Modified relaxin polypeptides and their uses
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
WO2012027611A2
(en)
*
|
2010-08-25 |
2012-03-01 |
Atyr Pharma, Inc. |
INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
|
CN103261222B
(zh)
|
2010-09-10 |
2017-07-28 |
医疗免疫有限公司 |
抗体衍生物
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
EP2624857B1
(en)
|
2010-10-06 |
2017-08-02 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl trna synthetases
|
WO2012048249A1
(en)
|
2010-10-07 |
2012-04-12 |
Yale University |
Site-specific incorporation of phosphoserine into proteins in escherichia coli
|
US9023791B2
(en)
|
2010-11-19 |
2015-05-05 |
Novartis Ag |
Fibroblast growth factor 21 mutations
|
CN103415621A
(zh)
|
2011-01-14 |
2013-11-27 |
雷德伍德生物科技股份有限公司 |
醛标记免疫球蛋白多肽及其使用方法
|
ES2661095T3
(es)
|
2011-02-03 |
2018-03-27 |
European Molecular Biology Laboratory |
Aminoácidos no naturales que comprenden un grupo análogo de ciclooctinilo o trans-ciclooctenilo y usos de los mismos
|
US9428789B2
(en)
|
2011-03-21 |
2016-08-30 |
Biodesy, Inc. |
Classification of kinase inhibitors using nonlinear optical techniques
|
WO2012131109A2
(en)
|
2011-04-01 |
2012-10-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaft e.V. |
Peptides and pharmaceutical compositions for use in the treatment by nasal administration of patients suffering from anxiety and sleep disorders
|
US9790262B2
(en)
|
2011-04-05 |
2017-10-17 |
Longevity Biotech, Inc. |
Compositions comprising glucagon analogs and methods of making and using the same
|
CN103702996A
(zh)
|
2011-05-27 |
2014-04-02 |
Ambrx公司 |
含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
|
WO2012166560A1
(en)
|
2011-05-27 |
2012-12-06 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
|
US10876142B2
(en)
|
2011-07-11 |
2020-12-29 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
US11788111B2
(en)
|
2011-07-11 |
2023-10-17 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
US10240158B2
(en)
|
2011-07-11 |
2019-03-26 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
WO2013009868A1
(en)
|
2011-07-11 |
2013-01-17 |
Yale University |
Compositions and methods for making selenocysteine containing polypeptides
|
CN102888387B
(zh)
*
|
2011-07-21 |
2015-03-18 |
中国科学院生物物理研究所 |
3-氯代酪氨酸翻译系统及其应用
|
EP3613852A3
(en)
|
2011-07-22 |
2020-04-22 |
President and Fellows of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
CN102925427B
(zh)
*
|
2011-08-08 |
2014-01-22 |
中国科学院生物物理研究所 |
丙烯酰赖氨酸翻译系统及其应用
|
WO2013022982A2
(en)
|
2011-08-09 |
2013-02-14 |
Atyr Pharma, Inc. |
Pegylated tyrosyl-trna synthetase polypeptides
|
TW201315742A
(zh)
|
2011-09-26 |
2013-04-16 |
Novartis Ag |
治療代謝病症之雙功能蛋白質
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
WO2013086216A1
(en)
|
2011-12-06 |
2013-06-13 |
Atyr Pharma, Inc. |
Improved aspartyl-trna synthetases
|
US9822353B2
(en)
|
2011-12-06 |
2017-11-21 |
Atyr Pharma, Inc. |
PEGylated aspartyl-tRNA synthetase polypeptides
|
JP6392123B2
(ja)
|
2011-12-20 |
2018-09-19 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
糖尿病治療のためのctp系インスリンアナローグ
|
TWI640541B
(zh)
|
2011-12-28 |
2018-11-11 |
中外製藥股份有限公司 |
Peptide compound having an annular portion and pharmaceutical composition thereof
|
CA2858613A1
(en)
|
2011-12-29 |
2013-08-08 |
Atyr Pharma, Inc. |
Aspartyl-trna synthetase-fc conjugates
|
US9395358B2
(en)
|
2012-02-05 |
2016-07-19 |
Biodesy, Inc. |
Methods for detecting allosteric modulators of protein
|
WO2013123432A2
(en)
|
2012-02-16 |
2013-08-22 |
Atyr Pharma, Inc. |
Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
|
SG11201406769RA
(en)
|
2012-05-10 |
2014-11-27 |
Massachusetts Inst Technology |
Agents for influenza neutralization
|
SG10201702176XA
(en)
|
2012-06-07 |
2017-04-27 |
Ambrx Inc |
Prostate-specific membrane antigen antibody drug conjugates
|
EP2859017B1
(en)
|
2012-06-08 |
2019-02-20 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
EP2861262B1
(en)
|
2012-06-19 |
2018-11-28 |
Ambrx, Inc. |
Anti-cd70 antibody drug conjugates
|
DK2863955T3
(en)
|
2012-06-26 |
2017-01-23 |
Sutro Biopharma Inc |
MODIFIED FC PROTEINS, INCLUDING LOCATION-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES THEREOF, METHODS OF PRODUCING ITS AND PROCEDURES FOR USE THEREOF
|
CN103571804B
(zh)
*
|
2012-08-10 |
2015-08-12 |
中国科学院生物物理研究所 |
3-吡唑基酪氨酸翻译系统及其应用
|
WO2014031861A1
(en)
|
2012-08-22 |
2014-02-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Engineered anthrax lethal toxin for targeted delivery
|
US8859735B2
(en)
|
2012-08-27 |
2014-10-14 |
Empire Technology Development Llc |
Gelatin alkyd peptides and uses thereof
|
EP3584255B1
(en)
|
2012-08-31 |
2022-02-16 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
EP2897935B1
(en)
|
2012-09-24 |
2019-02-27 |
MedImmune Limited |
Amino acid derivatives
|
EP3395358B1
(en)
|
2012-09-26 |
2019-11-06 |
Indiana University Research and Technology Corporation |
Insulin analog dimers
|
CN102875733B
(zh)
*
|
2012-10-25 |
2014-06-11 |
西安科技大学 |
具有仿细胞外层膜结构的纳米颗粒及其制备方法
|
US20140120116A1
(en)
|
2012-10-26 |
2014-05-01 |
The Chinese University Of Hong Kong |
Treatment of cancer using smad3 inhibitor
|
UY35144A
(es)
|
2012-11-20 |
2014-06-30 |
Novartis Ag |
Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
|
LT2935320T
(lt)
|
2012-12-18 |
2019-11-11 |
Novartis Ag |
Stabilizuoti insulino tipo augimo faktoriaus polipeptidai
|
EP2948469A4
(en)
|
2013-01-23 |
2016-11-02 |
Univ Leland Stanford Junior |
STABILIZED HEPATITIS B CORE POLYPEPTIDE
|
CA2902348C
(en)
|
2013-02-25 |
2021-11-30 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
US9255255B2
(en)
|
2013-03-04 |
2016-02-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Synthesis of linear and branched polymers of polypeptides through direct conjugation
|
UY35368A
(es)
|
2013-03-08 |
2014-10-31 |
Irm Llc |
Péptidos y composiciones para el tratamiento de daño articular
|
US20160024169A1
(en)
|
2013-03-14 |
2016-01-28 |
Indiana University Research And Technology Corporation |
Insulin-incretin conjugates
|
US9789164B2
(en)
|
2013-03-15 |
2017-10-17 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
CN105378075B
(zh)
|
2013-03-15 |
2022-04-05 |
Atyr 医药公司 |
组氨酰-trna合成酶-fc缀合物
|
WO2014145654A1
(en)
*
|
2013-03-15 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Method for the site-specific covalent cross-linking of antibodies to surfaces
|
JP6574754B2
(ja)
|
2013-03-19 |
2019-09-11 |
ベイジン シェノゲン ファーマ グループ リミテッド |
エストロゲン受容体関連疾患を処置するための抗体及び方法
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|
KR101568336B1
(ko)
|
2013-07-02 |
2015-11-12 |
서강대학교산학협력단 |
목적 단백질의 돌연변이체를 생성하는 세포, 상기 세포의 제조 방법, 및 상기 세포를 이용한 목적 단백질의 돌연변이체의 제조 방법
|
US9764039B2
(en)
|
2013-07-10 |
2017-09-19 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
US10005838B2
(en)
|
2013-07-19 |
2018-06-26 |
The Regents Of The University Of California |
Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
|
MX2016001020A
(es)
|
2013-07-25 |
2016-08-03 |
Novartis Ag |
Polipeptidos ciclicos para el tratamiento de insuficiencia cardiaca.
|
US9340582B2
(en)
|
2013-07-25 |
2016-05-17 |
Novartis Ag |
Bioconjugates of synthetic apelin polypeptides
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
WO2015021358A2
(en)
|
2013-08-09 |
2015-02-12 |
Dominique Charmot |
Compounds and methods for inhibiting phosphate transport
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US10011649B2
(en)
|
2013-08-26 |
2018-07-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
High affinity synbodies for influenza
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
EA201690732A1
(ru)
|
2013-10-10 |
2016-12-30 |
Синерджи Фармасьютикалз, Инк. |
Агонисты гуанилатциклазы, используемые для лечения индуцированных опиоидами дисфункций
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
EP3057605A1
(en)
|
2013-10-18 |
2016-08-24 |
Novartis AG |
Methods of treating diabetes and related disorders
|
US9068179B1
(en)
|
2013-12-12 |
2015-06-30 |
President And Fellows Of Harvard College |
Methods for correcting presenilin point mutations
|
JP6479022B2
(ja)
|
2014-01-14 |
2019-03-06 |
ヨーロピアン モレキュラー バイオロジー ラボラトリーEuropean Molecular Biology Laboratory |
分子標識のための複数の環化付加反応
|
WO2015120287A2
(en)
*
|
2014-02-06 |
2015-08-13 |
Yale University |
Compositions and methods of use thereof for making polypeptides with many instances of nonstandard amino acids
|
ES2913205T3
(es)
|
2014-05-13 |
2022-06-01 |
Bioatla Inc |
Proteínas biológicas activas condicionalmente
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
WO2015200080A1
(en)
|
2014-06-23 |
2015-12-30 |
Novartis Ag |
Site specific protein modifications
|
WO2016004024A1
(en)
|
2014-07-02 |
2016-01-07 |
Sutro Biopharma, Inc. |
High growth capacity auxotrophic escherichia coli and methods of use
|
EP3169776A4
(en)
|
2014-07-14 |
2018-07-04 |
The Regents of The University of California |
Crispr/cas transcriptional modulation
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
WO2016036916A1
(en)
|
2014-09-03 |
2016-03-10 |
Bioatla, Llc |
Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts
|
WO2016049190A1
(en)
|
2014-09-24 |
2016-03-31 |
Indiana University Research And Technology Corporation |
Incretin-insulin conjugates
|
JP6701208B2
(ja)
|
2014-09-24 |
2020-05-27 |
インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション |
脂質化アミド系インスリンプロドラッグ
|
WO2016073079A2
(en)
|
2014-09-26 |
2016-05-12 |
Yale University |
Compositions and methods for biocontainment of microorganisms
|
UY36370A
(es)
|
2014-10-24 |
2016-04-29 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Polipéptidos fgf-21 modificados y sus usos
|
SG10202008302XA
(en)
|
2014-12-04 |
2020-10-29 |
Celgene Corp |
Biomolecule conjugates
|
WO2016106286A1
(en)
|
2014-12-23 |
2016-06-30 |
Biodesy, Inc. |
Attachment of proteins to interfaces for use in nonlinear optical detection
|
SE538541C2
(en)
*
|
2015-01-19 |
2016-09-13 |
Fogelstrand Per |
Method for preparing a biological sample for use in an immunolabeling process
|
AU2016209968B2
(en)
|
2015-01-23 |
2018-11-29 |
Novartis Ag |
Synthetic apelin fatty acid conjugates with improved half-life
|
ES2880473T5
(es)
|
2015-01-30 |
2024-05-09 |
Univ California |
Suministro de proteínas en células hematopoyéticas primarias
|
JP7020910B2
(ja)
|
2015-03-13 |
2022-02-16 |
中外製薬株式会社 |
改変アミノアシルtRNA合成酵素およびその用途
|
US10483262B2
(en)
*
|
2015-05-15 |
2019-11-19 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Dual nitride stressor for semiconductor device and method of manufacturing
|
WO2016199801A1
(ja)
*
|
2015-06-09 |
2016-12-15 |
国立研究開発法人産業技術総合研究所 |
アミノ酸修飾核酸とその利用
|
ES2826827T3
(es)
|
2015-06-15 |
2021-05-19 |
Angiochem Inc |
Métodos para el tratamiento de carcinomatosis leptomeníngea
|
EP3331551B1
(en)
|
2015-07-10 |
2021-06-23 |
The Hong Kong University of Science and Technology |
Compositions for use in treating neurodegenerative and neuroinflammatory conditions
|
WO2017062334A1
(en)
|
2015-10-05 |
2017-04-13 |
Merck Sharp & Dohme Corp. |
Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
|
CN108513575A
(zh)
|
2015-10-23 |
2018-09-07 |
哈佛大学的校长及成员们 |
核碱基编辑器及其用途
|
JP6946304B2
(ja)
|
2015-12-22 |
2021-10-06 |
ノバルティス アーゲー |
増殖分化因子15(gdf−15)を使用して代謝障害を処置するまたは軽快させる方法
|
MX2018007859A
(es)
|
2015-12-23 |
2018-11-09 |
Amgen Inc |
Metodo para tratar o mejorar trastornos metabolicos con proteinas de union para el receptor peptidico inhibidor gastrico (gipr) en combinacion con agonistas de glp-1.
|
CN106929482A
(zh)
*
|
2015-12-31 |
2017-07-07 |
北京大学 |
定点突变的流感病毒、其活疫苗及其制备方法和应用
|
WO2017123634A1
(en)
|
2016-01-11 |
2017-07-20 |
Synergy Pharmaceuticals, Inc. |
Formulations and methods for treating ulcerative colitis
|
RU2018130757A
(ru)
|
2016-01-27 |
2020-02-27 |
Сутро Биофарма, Инк. |
Конъюгаты антитела к cd74, композиции, содержащие конъюгаты антитела к cd74, и способы использования конъюгатов антитела к cd74
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール.ピー.シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
EP3455628A4
(en)
|
2016-05-09 |
2019-12-04 |
Biodesy, Inc. |
METHOD AND DEVICES FOR DETECTING INTERACTIONS OF PERIPHERAL MEMBRANE PROTEINS USING NONLINEAR OPTICAL TECHNIQUES
|
EP3465204B1
(en)
*
|
2016-05-25 |
2023-08-02 |
Kromnigon AB |
Method for preparing a biological sample for use in an immunolabeling process
|
KR102492057B1
(ko)
|
2016-06-15 |
2023-01-26 |
노파르티스 아게 |
골 형태형성 단백질 6(bmp6)의 억제제를 사용한 질병의 치료 방법
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
CA3033327A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
WO2018039438A1
(en)
*
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
EP3309260A1
(en)
|
2016-10-14 |
2018-04-18 |
European Molecular Biology Laboratory |
Archaeal pyrrolysyl trna synthetases for orthogonal use
|
WO2018087720A1
(en)
|
2016-11-14 |
2018-05-17 |
Novartis Ag |
Compositions, methods, and therapeutic uses related to fusogenic protein minion
|
JP2019535707A
(ja)
|
2016-11-14 |
2019-12-12 |
ノバルティス アーゲー |
軟骨損傷および関節炎の処置のための方法および組成物
|
JP2020501573A
(ja)
|
2016-12-19 |
2020-01-23 |
クアンタム−エスアイ インコーポレイテッドQuantum−Si Incorporated |
シークエンシング反応用の重合酵素
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
MA47223A
(fr)
|
2016-12-30 |
2019-11-06 |
Sutrovax Inc |
Conjugués polypeptide-antigène avec des acides aminés non naturels
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
ES2963839T3
(es)
|
2017-02-08 |
2024-04-02 |
Bristol Myers Squibb Co |
Polipéptidos de relaxina modificados que comprenden un potenciador farmacocinético y usos de los mismos
|
EP3592853A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Suppression of pain by gene editing
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
SG11201908658TA
(en)
|
2017-03-23 |
2019-10-30 |
Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
EP3381932A1
(en)
|
2017-03-28 |
2018-10-03 |
Technische Universität Berlin |
Modified mussel proteins, uses thereof and related compounds
|
JP2020517638A
(ja)
|
2017-04-20 |
2020-06-18 |
エータイアー ファーマ, インコーポレイテッド |
肺の炎症を治療するための組成物および方法
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
LT3630977T
(lt)
|
2017-06-02 |
2024-04-25 |
Ambrx, Inc. |
Baltymų, kurių sudėtyje yra negamtinių aminorūgščių, gamybos skatinimo būdai ir kompozicijos
|
EP3636656A4
(en)
|
2017-06-09 |
2021-04-14 |
Chugai Seiyaku Kabushiki Kaisha |
PROCESS FOR SYNTHESIS OF A PEPTIDE CONTAINING AN N-SUBSTITUTED AMINO ACID
|
CA3069321A1
(en)
*
|
2017-07-11 |
2019-01-17 |
Synthorx, Inc. |
Incorporation of unnatural nucleotides and methods thereof
|
KR101956042B1
(ko)
*
|
2017-07-13 |
2019-03-08 |
서강대학교산학협력단 |
표적 단백질 내 l-디하이드록시페닐알라닌의 도입 방법
|
WO2019023316A1
(en)
|
2017-07-26 |
2019-01-31 |
Sutro Biopharma, Inc. |
METHODS OF USING ANTI-CD74 ANTIBODIES AND ANTIBODY CONJUGATES IN THE TREATMENT OF A T CELL LYMPHOMA
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
AU2018309166B2
(en)
|
2017-08-03 |
2022-12-08 |
Synthorx, Inc. |
Cytokine conjugates for the treatment of proliferative and infectious diseases
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
CN111315768A
(zh)
|
2017-09-07 |
2020-06-19 |
库尔生物制药有限公司 |
具有缀合位点的t细胞调节性多聚体多肽及其使用方法
|
KR20200051802A
(ko)
|
2017-09-18 |
2020-05-13 |
서트로 바이오파마, 인크. |
항-엽산 수용체 알파 항체 접합체 및 이의 용도
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
JP7411414B2
(ja)
|
2017-12-15 |
2024-01-11 |
中外製薬株式会社 |
ペプチドの製造方法、及び塩基の処理方法
|
WO2019213331A1
(en)
|
2018-05-01 |
2019-11-07 |
Ambrx, Inc. |
A method for optimizing antibody expression
|
WO2019237119A1
(en)
|
2018-06-08 |
2019-12-12 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and detection methods for onchocerca volvulus infection
|
JP2021536263A
(ja)
*
|
2018-09-07 |
2021-12-27 |
メディミューン,エルエルシー |
細胞選択の方法
|
HRP20240016T1
(hr)
|
2018-09-11 |
2024-03-29 |
Ambrx, Inc. |
Konjugati polipeptida interleukina-2 i njihove uporabe
|
WO2020060944A1
(en)
|
2018-09-17 |
2020-03-26 |
Sutro Biopharma, Inc. |
Combination therapies with anti-folate receptor antibody conjugates
|
CN113366015A
(zh)
|
2018-10-19 |
2021-09-07 |
Ambrx公司 |
白细胞介素-10多肽缀合物、其二聚体及其用途
|
WO2020097261A1
(en)
|
2018-11-06 |
2020-05-14 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and methods for treating beta-globinopathies
|
WO2020111238A1
(ja)
|
2018-11-30 |
2020-06-04 |
中外製薬株式会社 |
ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法
|
SG11202107354WA
(en)
|
2019-02-06 |
2021-08-30 |
Synthorx Inc |
Il-2 conjugates and methods of use thereof
|
BR112021015832A2
(pt)
|
2019-02-12 |
2022-01-18 |
Ambrx Inc |
Composições que contêm conjugados de anticorpo-agonista de tlr, métodos e usos dos mesmos
|
EP3696189A1
(en)
|
2019-02-14 |
2020-08-19 |
European Molecular Biology Laboratory |
Means and methods for preparing engineered target proteins by genetic code expansion in a target protein selective manner
|
CN113785058A
(zh)
*
|
2019-03-04 |
2021-12-10 |
得克萨斯A&M大学系统 |
制作和利用琥珀专性的噬菌体展示文库的方法
|
DE112020001342T5
(de)
|
2019-03-19 |
2022-01-13 |
President and Fellows of Harvard College |
Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen
|
WO2020227105A1
(en)
|
2019-05-03 |
2020-11-12 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
US20220234995A1
(en)
*
|
2019-05-20 |
2022-07-28 |
Albert Einstein College Of Medicine |
Compounds and methods for treatment of bacterial infections
|
EP3980057A1
(en)
|
2019-06-04 |
2022-04-13 |
Institut Curie |
Methods of producing shiga toxin b-subunit (stxb) monomers and oligomers, and uses thereof
|
JP2022536490A
(ja)
|
2019-06-10 |
2022-08-17 |
ストロ バイオファーマ インコーポレーテッド |
5H-ピロロ[3,2-d]ピリミジン-2,4-ジアミノ化合物およびその抗体コンジュゲート
|
WO2020257235A1
(en)
|
2019-06-17 |
2020-12-24 |
Sutro Biopharma, Inc. |
1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis
|
US11959105B2
(en)
|
2019-06-28 |
2024-04-16 |
Quantum-Si Incorporated |
Polymerizing enzymes for sequencing reactions
|
WO2021072129A2
(en)
|
2019-10-08 |
2021-04-15 |
Trustees Of Boston College |
Proteins containing multiple, different unnatural amino acids and methods of making and using such proteins
|
TW202128996A
(zh)
*
|
2019-10-10 |
2021-08-01 |
美商史基普研究協會 |
用於活體內合成非天然多肽的組合物及方法
|
US11149280B2
(en)
|
2019-10-29 |
2021-10-19 |
Yale University |
Engineering organisms resistant to viruses and horizontally transferred genetic elements
|
WO2021092162A1
(en)
*
|
2019-11-05 |
2021-05-14 |
Aditya Kunjapur |
Biosynthesis of para-nitro-l-phenylalanine
|
CN113597434B
(zh)
|
2019-12-31 |
2022-07-01 |
北京质肽生物医药科技有限公司 |
Glp-1和gdf15的融合蛋白以及其缀合物
|
EP4084819A1
(en)
|
2020-01-03 |
2022-11-09 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Tnap locally administered for promoting periodontal health
|
CN113728013B
(zh)
|
2020-01-11 |
2022-06-14 |
北京质肽生物医药科技有限公司 |
Glp-1和fgf21的融合蛋白的缀合物
|
WO2021165968A1
(en)
*
|
2020-02-20 |
2021-08-26 |
B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University |
Mutant aminoacyl-trna synthetases
|
EP3868882A1
(en)
|
2020-02-21 |
2021-08-25 |
European Molecular Biology Laboratory |
Archaeal pyrrolysyl trna synthetases for orthogonal use
|
US20230095053A1
(en)
|
2020-03-03 |
2023-03-30 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
|
WO2021183832A1
(en)
|
2020-03-11 |
2021-09-16 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and methods of use thereof
|
CN111302975A
(zh)
*
|
2020-03-30 |
2020-06-19 |
滨海吉尔多肽有限公司 |
一种n-叔丁氧羰基-o-烯丙基-l-酪氨酸的制备方法
|
TW202203973A
(zh)
|
2020-04-22 |
2022-02-01 |
美商默沙東藥廠 |
對介白素-2受體βγc二聚體具偏性且結合至非肽、水溶性聚合物之人類介白素-2結合物
|
US20210340586A1
(en)
|
2020-04-30 |
2021-11-04 |
Sutro Biopharma, Inc. |
Methods of Producing Full-Length Antibodies Using E. coli
|
CN115551875A
(zh)
|
2020-05-05 |
2022-12-30 |
基因泰克公司 |
用于酪氨酸酶介导的位点特异性蛋白质缀合的系统和方法
|
EP4146804A1
(en)
|
2020-05-08 |
2023-03-15 |
The Broad Institute Inc. |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
WO2021234458A1
(en)
|
2020-05-22 |
2021-11-25 |
Takeda Pharmaceutical Company Limited |
Adamts13 compositions and methods for treating and diagnosing complications of coronavirus disease
|
AU2021327396A1
(en)
|
2020-08-20 |
2023-03-23 |
Ambrx, Inc. |
Antibody-TLR agonist conjugates, methods and uses thereof
|
KR20230069187A
(ko)
*
|
2020-09-14 |
2023-05-18 |
서트로 바이오파마, 인크. |
무세포 단백질 합성 시스템을 이용한 항체의 대량 생산 방법
|
CN115925995A
(zh)
|
2020-09-30 |
2023-04-07 |
北京质肽生物医药科技有限公司 |
多肽缀合物和使用方法
|
AU2022249223A1
(en)
|
2021-04-03 |
2023-10-12 |
Ambrx, Inc. |
Anti-her2 antibody-drug conjugates and uses thereof
|
US20230016731A1
(en)
*
|
2021-05-21 |
2023-01-19 |
The Regents Of The University Of California |
Affinity purification sequencing
|
KR20240041378A
(ko)
|
2021-07-09 |
2024-03-29 |
브라이트 피크 테라퓨틱스 아게 |
체크포인트 억제제와 il-2의 접합체 및 이의 용도
|
WO2023281482A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Cd20-targeted il-2 and its uses
|
US20230250181A1
(en)
|
2021-07-09 |
2023-08-10 |
Bright Peak Therapeutics Ag |
Modified checkpoint inhibitors and uses thereof
|
WO2023281485A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Modified il-2 polypeptides for treatment of inflammatory and autoimmune diseases
|
WO2023281481A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics |
Antibody conjugates and manufacture thereof
|
CN118339280A
(zh)
|
2021-09-06 |
2024-07-12 |
维拉克萨生物技术有限责任公司 |
用于真核生物中遗传密码子扩展的新型氨酰tRNA合成酶变体
|
IL311389A
(en)
*
|
2021-09-17 |
2024-05-01 |
Absci Corp |
Transfer RNA composition and use in the production of proteins containing non-standard amino acids
|
WO2023069816A2
(en)
|
2021-09-20 |
2023-04-27 |
The Broad Institute, Inc. |
Compositions and methods for multiplex decoding of quadruplet codons
|
WO2023081167A2
(en)
|
2021-11-02 |
2023-05-11 |
The Regents Of The University Of California |
P-selectin mutants and modulation of integrin-mediated signaling
|
WO2023094525A1
(en)
|
2021-11-25 |
2023-06-01 |
Veraxa Biotech Gmbh |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
EP4186529A1
(en)
|
2021-11-25 |
2023-05-31 |
Veraxa Biotech GmbH |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
CA3239713A1
(en)
|
2021-12-08 |
2023-06-15 |
Edward A. LEMKE |
Hydrophilic tetrazine-functionalized payloads for preparation of targeting conjugates
|
WO2023146807A1
(en)
|
2022-01-25 |
2023-08-03 |
The Regents Of The University Of California |
Vegf mutants and modulation of integrin-mediated signaling
|
US20240132563A1
(en)
|
2022-02-23 |
2024-04-25 |
Bright Peak Therapeutics Ag |
Bifunctional cytokine compositions
|
WO2023161854A1
(en)
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
TW202408589A
(zh)
|
2022-06-30 |
2024-03-01 |
美商舒卓生物製藥公司 |
抗ror1抗體及抗體結合物、包含抗ror1抗體或抗體結合物之組合物,及製造及使用抗ror1抗體及抗體結合物之方法
|
NL2033185B1
(en)
|
2022-09-29 |
2024-04-08 |
Stichting Vu |
Compounds for rna stabilisation and delivery
|
WO2024077277A1
(en)
|
2022-10-07 |
2024-04-11 |
Ambrx, Inc. |
Drug linkers and antibody conjugates thereof
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|